APA (7th ed.) Citation

Han, R., Yang, H., Lu, L., & Lin, L. (2021). Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Nature Portfolio.

Chicago Style (17th ed.) Citation

Han, Rui, Hongxing Yang, Lingeng Lu, and Lizhu Lin. Tiliroside as a CAXII Inhibitor Suppresses Liver Cancer Development and Modulates E2Fs/Caspase-3 Axis. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Han, Rui, et al. Tiliroside as a CAXII Inhibitor Suppresses Liver Cancer Development and Modulates E2Fs/Caspase-3 Axis. Nature Portfolio, 2021.